{"pmid":32379928,"title":"Do we really need guidelines for HRA during COVID-19 pandemic?","text":["Do we really need guidelines for HRA during COVID-19 pandemic?","Severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2) was first identified in Wuhan, China, in December 2019. Since then the World Health Organization declared the outbreak to be a Public Health Emergency of International Concern on 30 January 2020, and then recognized it as a pandemic on 11 March 2020. Consequent to COVID-19 pandemic, all International and National Societies published countless guidelines about the management of patients affected by COVID-19. In spite of this IANS proposed its guidelines for the use of HRA in anal cancer and its precursors. Considering the costs to deal with COVID-19, the deficiency of healthcare professionals and the lack of worldwide evidence consensus on HRA, this examination cannot be considered mandatory during the COVID-19 pandemic. DARE with biopsy of suspicious palpable lesions in symptomatic patients could be considered enough during this period. Probably a latency of 6-12 months is reasonable for these patients without affecting the natural history of AIN. In conclusion, the current Covid-19 pandemic has been the most discussed topic in the media and scientific journals. However a deluge of scientific publications results in worldwide uncertainty. Guidelines on this topic should only be based on validated studies which support an Evidence Based Medicine approach. In our opinion this is not the case for HRA.","Colorectal Dis","Mistrangelo, Massimiliano","Naldini, Gabriele","Morino, Mario","32379928"],"abstract":["Severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2) was first identified in Wuhan, China, in December 2019. Since then the World Health Organization declared the outbreak to be a Public Health Emergency of International Concern on 30 January 2020, and then recognized it as a pandemic on 11 March 2020. Consequent to COVID-19 pandemic, all International and National Societies published countless guidelines about the management of patients affected by COVID-19. In spite of this IANS proposed its guidelines for the use of HRA in anal cancer and its precursors. Considering the costs to deal with COVID-19, the deficiency of healthcare professionals and the lack of worldwide evidence consensus on HRA, this examination cannot be considered mandatory during the COVID-19 pandemic. DARE with biopsy of suspicious palpable lesions in symptomatic patients could be considered enough during this period. Probably a latency of 6-12 months is reasonable for these patients without affecting the natural history of AIN. In conclusion, the current Covid-19 pandemic has been the most discussed topic in the media and scientific journals. However a deluge of scientific publications results in worldwide uncertainty. Guidelines on this topic should only be based on validated studies which support an Evidence Based Medicine approach. In our opinion this is not the case for HRA."],"journal":"Colorectal Dis","authors":["Mistrangelo, Massimiliano","Naldini, Gabriele","Morino, Mario"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32379928","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/codi.15116","keywords":["covid-19","hsil","anal cancer","high resolution anoscopy","human papillomavirus"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666597097315500033,"score":9.490897,"similar":[{"pmid":32236295,"title":"The surgeons and the COVID-19 pandemic.","text":["The surgeons and the COVID-19 pandemic.","The current world Covid-19 pandemic has been the most discussed topic in the media and scientific journals. Fear, uncertainty, and lack of knowledge about the disease may be the significant factors that justify such reality. It has been known that the disease presents with a rapidly spreading, it is significantly more severe among the elderly, and it has a substantial global socioeconomic impact. Besides the challenges associated with the unknown, there are other factors, such as the deluge of information. In this regard, the high number of scientific publications, encompassing in vitro, case studies, observational and randomized clinical studies, and even systematic reviews add up to the uncertainty. Such a situation is even worse when considering that most healthcare professionals lack adequate knowledge to critically appraise the scientific method, something that has been previously addressed by some authors. Therefore, it is of utmost importance that expert societies supported by data provided by the World Health Organization and the National Health Department take the lead in spreading trustworthy and reliable information. The Brazilian College of Surgeons suggests in this document various initiatives that may help surgeons, healthcare providers, and patients who will have to face a surgical event under the pandemic.","Rev Col Bras Cir","Correia, M Isabel T D","Ramos, Rodrigo Felippe","Bahten, Luiz Carlos Von","32236295"],"abstract":["The current world Covid-19 pandemic has been the most discussed topic in the media and scientific journals. Fear, uncertainty, and lack of knowledge about the disease may be the significant factors that justify such reality. It has been known that the disease presents with a rapidly spreading, it is significantly more severe among the elderly, and it has a substantial global socioeconomic impact. Besides the challenges associated with the unknown, there are other factors, such as the deluge of information. In this regard, the high number of scientific publications, encompassing in vitro, case studies, observational and randomized clinical studies, and even systematic reviews add up to the uncertainty. Such a situation is even worse when considering that most healthcare professionals lack adequate knowledge to critically appraise the scientific method, something that has been previously addressed by some authors. Therefore, it is of utmost importance that expert societies supported by data provided by the World Health Organization and the National Health Department take the lead in spreading trustworthy and reliable information. The Brazilian College of Surgeons suggests in this document various initiatives that may help surgeons, healthcare providers, and patients who will have to face a surgical event under the pandemic."],"journal":"Rev Col Bras Cir","authors":["Correia, M Isabel T D","Ramos, Rodrigo Felippe","Bahten, Luiz Carlos Von"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32236295","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1590/0100-6991e-20202536","topics":["Prevention"],"weight":1,"_version_":1666138490442612736,"score":194.78346},{"pmid":32292260,"pmcid":"PMC7141449","title":"Guidelines for dental care provision during the COVID-19 pandemic.","text":["Guidelines for dental care provision during the COVID-19 pandemic.","Since the coronavirus disease 2019 (COVID-19) outbreak was declared a pandemic on 11 March 2020. Several dental care facilities in affected countries have been completely closed or have been only providing minimal treatment for emergency cases. However, several facilities in some affected countries are still providing regular dental treatment. This can in part be a result of the lack of universal protocol or guidelines regulating the dental care provision during such a pandemic. This lack of guidelines can on one hand increase the nosocomial COVID-19 spread through dental health care facilities, and on the other hand deprive patients' in need of the required urgent dental care. Moreover, ceasing dental care provision during such a period will incense the burden on hospitals emergency departments already struggle with the pandemic. This work aimed to develop guidelines for dental patients' management during and after the COVID-19 pandemic. Guidelines for dental care provision during the COVID-19 pandemic were developed after considering the nature of COVID-19 pandemic, and were based on grouping the patients according to condition and need, and considering the procedures according to risk and benefit. It is hoped that the guidelines proposed in this work will help in the management of dental care around the world during and after this COVID-19 pandemic.","Saudi Dent J","Alharbi, Ali","Alharbi, Saad","Alqaidi, Shahad","32292260"],"abstract":["Since the coronavirus disease 2019 (COVID-19) outbreak was declared a pandemic on 11 March 2020. Several dental care facilities in affected countries have been completely closed or have been only providing minimal treatment for emergency cases. However, several facilities in some affected countries are still providing regular dental treatment. This can in part be a result of the lack of universal protocol or guidelines regulating the dental care provision during such a pandemic. This lack of guidelines can on one hand increase the nosocomial COVID-19 spread through dental health care facilities, and on the other hand deprive patients' in need of the required urgent dental care. Moreover, ceasing dental care provision during such a period will incense the burden on hospitals emergency departments already struggle with the pandemic. This work aimed to develop guidelines for dental patients' management during and after the COVID-19 pandemic. Guidelines for dental care provision during the COVID-19 pandemic were developed after considering the nature of COVID-19 pandemic, and were based on grouping the patients according to condition and need, and considering the procedures according to risk and benefit. It is hoped that the guidelines proposed in this work will help in the management of dental care around the world during and after this COVID-19 pandemic."],"journal":"Saudi Dent J","authors":["Alharbi, Ali","Alharbi, Saad","Alqaidi, Shahad"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292260","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.sdentj.2020.04.001","topics":["Prevention"],"weight":1,"_version_":1666138494393647104,"score":165.06892},{"pmid":32410896,"pmcid":"PMC7219724","title":"Public Health Aspects of COVID-19 Infection with Focus on Cardiovascular Diseases.","text":["Public Health Aspects of COVID-19 Infection with Focus on Cardiovascular Diseases.","Introduction: COVID-19 is the disease caused by an infection of the SARS-CoV-2 virus, first identified in the city of Wuhan, in China's Hubei province in December 2019. COVID-19 was previously known as 2019 Novel Coronavirus (2019-nCoV) respiratory disease before the World Health Organization (WHO) declared the official name as COVID-19 in February 2020. Aim: The aim of this study is to search scientific literature in the biomedicine and analyzed current results of investigations regarding morbidity and mortality rates as consequences of COVID-19 infection of Cardiovascular diseases (CVD), and other most common chronic diseases which are on the top mortality and morbidity rates in almost all countries in the world. Also, to propose most useful measures how to prevent patients to keep themselves against COVID-19 infection. Methods: We used method of descriptive analysis of the published papers with described studies about Corona virus connected with CVD, and, also, Guidelines proposed by World Health Organization (WHO) and European Society of Cardiology (ESC), and some other international associations which are included in global fighting against COVID-19 infection. Results: After searching current scientific literature we have acknowledged that not any Evidence Based Medicine (EBM) study in the world during last 5 months from the time when first cases of COVID-10 infection was detected. Also, there is no unique proposed ways of treatments and drugs to protect patients, especially people over 65 years old, who are very risk group to be affected with COVID-19. Expectations that vaccine against COVID-19 will be produced optimal during at least 10 months to 2 years, and in all current Guidelines most important proposed preventive measures are the same like which one described in Strategic documents of WHO, in statements of Declaration of Primary Health Care in Alma Ata in 1978. Conclusion: WHO proposed preventive measures can be helpful to everybody. Physicians who work at every level of Health Care Systems, but especially at primary health care level, must follow those recommendations and teach their patients about it. But, the fact is that current focus of COVID-19 epidemic has targeted on protection of physical health of population in global, however, the influence on mental health which will be one of the important consequences of COVID-19 pandemic in the future, and which could be declared as <<Post-coronavirus Stress Syndrome\" (PCSS) could be bigger challenge for Global Public Health.","Mater Sociomed","Masic, Izet","Naser, Nabil","Zildzic, Muharem","32410896"],"abstract":["Introduction: COVID-19 is the disease caused by an infection of the SARS-CoV-2 virus, first identified in the city of Wuhan, in China's Hubei province in December 2019. COVID-19 was previously known as 2019 Novel Coronavirus (2019-nCoV) respiratory disease before the World Health Organization (WHO) declared the official name as COVID-19 in February 2020. Aim: The aim of this study is to search scientific literature in the biomedicine and analyzed current results of investigations regarding morbidity and mortality rates as consequences of COVID-19 infection of Cardiovascular diseases (CVD), and other most common chronic diseases which are on the top mortality and morbidity rates in almost all countries in the world. Also, to propose most useful measures how to prevent patients to keep themselves against COVID-19 infection. Methods: We used method of descriptive analysis of the published papers with described studies about Corona virus connected with CVD, and, also, Guidelines proposed by World Health Organization (WHO) and European Society of Cardiology (ESC), and some other international associations which are included in global fighting against COVID-19 infection. Results: After searching current scientific literature we have acknowledged that not any Evidence Based Medicine (EBM) study in the world during last 5 months from the time when first cases of COVID-10 infection was detected. Also, there is no unique proposed ways of treatments and drugs to protect patients, especially people over 65 years old, who are very risk group to be affected with COVID-19. Expectations that vaccine against COVID-19 will be produced optimal during at least 10 months to 2 years, and in all current Guidelines most important proposed preventive measures are the same like which one described in Strategic documents of WHO, in statements of Declaration of Primary Health Care in Alma Ata in 1978. Conclusion: WHO proposed preventive measures can be helpful to everybody. Physicians who work at every level of Health Care Systems, but especially at primary health care level, must follow those recommendations and teach their patients about it. But, the fact is that current focus of COVID-19 epidemic has targeted on protection of physical health of population in global, however, the influence on mental health which will be one of the important consequences of COVID-19 pandemic in the future, and which could be declared as <<Post-coronavirus Stress Syndrome\" (PCSS) could be bigger challenge for Global Public Health."],"journal":"Mater Sociomed","authors":["Masic, Izet","Naser, Nabil","Zildzic, Muharem"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32410896","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.5455/msm.2020.32.71-76","keywords":["covid-19","cvds","chronic diseases","post-coronavirus stress syndrome - pcss","public health","who guidelines"],"locations":["Wuhan","China","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666989866094690304,"score":158.29747},{"pmid":32443538,"title":"SARS-CoV-2 in Pregnancy: A Comprehensive Summary of Current Guidelines.","text":["SARS-CoV-2 in Pregnancy: A Comprehensive Summary of Current Guidelines.","Since the declaration of the global pandemic of COVID-19 by the World Health Organization on 11 March 2020, we have continued to see a steady rise in the number of patients infected by SARS-CoV-2. However, there is still very limited data on the course and outcomes of this serious infection in a vulnerable population of pregnant patients and their fetuses. International perinatal societies and institutions including SMFM, ACOG, RCOG, ISUOG, CDC, CNGOF, ISS/SIEOG, and CatSalut have released guidelines for the care of these patients. We aim to summarize these current guidelines in a comprehensive review for patients, healthcare workers, and healthcare institutions. We included 15 papers from 10 societies through a literature search of direct review of society's websites and their journal publications up till 20 April 2020. Recommendations specific to antepartum, intrapartum, and postpartum were abstracted from the publications and summarized into Tables. The summary of guidelines for the management of COVID-19 in pregnancy across different perinatal societies is fairly consistent, with some variation in the strength of recommendations. It is important to recognize that these guidelines are frequently updated, as we continue to learn more about the course and impact of COVID-19 in pregnancy.","J Clin Med","Narang, Kavita","Ibirogba, Eniola R","Elrefaei, Amro","Trad, Ayssa Teles Abrao","Theiler, Regan","Nomura, Roseli","Picone, Olivier","Kilby, Mark","Escuriet, Ramon","Suy, Anna","Carreras, Elena","Tonni, Gabriele","Ruano, Rodrigo","32443538"],"abstract":["Since the declaration of the global pandemic of COVID-19 by the World Health Organization on 11 March 2020, we have continued to see a steady rise in the number of patients infected by SARS-CoV-2. However, there is still very limited data on the course and outcomes of this serious infection in a vulnerable population of pregnant patients and their fetuses. International perinatal societies and institutions including SMFM, ACOG, RCOG, ISUOG, CDC, CNGOF, ISS/SIEOG, and CatSalut have released guidelines for the care of these patients. We aim to summarize these current guidelines in a comprehensive review for patients, healthcare workers, and healthcare institutions. We included 15 papers from 10 societies through a literature search of direct review of society's websites and their journal publications up till 20 April 2020. Recommendations specific to antepartum, intrapartum, and postpartum were abstracted from the publications and summarized into Tables. The summary of guidelines for the management of COVID-19 in pregnancy across different perinatal societies is fairly consistent, with some variation in the strength of recommendations. It is important to recognize that these guidelines are frequently updated, as we continue to learn more about the course and impact of COVID-19 in pregnancy."],"journal":"J Clin Med","authors":["Narang, Kavita","Ibirogba, Eniola R","Elrefaei, Amro","Trad, Ayssa Teles Abrao","Theiler, Regan","Nomura, Roseli","Picone, Olivier","Kilby, Mark","Escuriet, Ramon","Suy, Anna","Carreras, Elena","Tonni, Gabriele","Ruano, Rodrigo"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32443538","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.3390/jcm9051521","keywords":["covid-19","sars-cov-2","coronavirus","guidelines","pandemic","perinatal","pregnancy","prevention","screening"],"topics":["Prevention"],"weight":1,"_version_":1667600475748302848,"score":144.76173},{"pmid":32340549,"title":"Evidence-Based Guidelines for Management of Head and Neck Mucosal Malignancies during the COVID-19 Pandemic.","text":["Evidence-Based Guidelines for Management of Head and Neck Mucosal Malignancies during the COVID-19 Pandemic.","OBJECTIVE: Due to the current coronavirus disease 2019 (COVID-19) pandemic, otolaryngologists face novel challenges when treating patients with head and neck cancer. The purpose of this review is to evaluate the current evidence surrounding the treatment of these patients during this pandemic and to provide evidence-based recommendations with attention to increased risk in this setting. DATA SOURCES: A review of the literature was performed with PubMed. Because recently published articles on this topic may not yet be indexed into PubMed, otolaryngology journals were hand searched for relevant articles. Guidelines from national organizations were reviewed to identify additional relevant sources of information. REVIEW METHODS: Two groups of search terms were created: one with terms related to COVID-19 and another with terms related to head and neck cancer and its management. Searches were performed of all terms in each group as well as combinations of terms between groups. Searches and subsequent exclusion of articles were performed in accordance with the PRISMA guidelines (Preferred Reporting Items for Systematic Reviews and Meta-analyses). Additional articles were identified after relevant journals and guidelines from national organizations were reviewed. CONCLUSIONS: Patients with head and neck mucosal malignancy require continued treatment despite the current pandemic state. Care must be taken at all stages of treatment to minimize the risk to patients and health care workers while maintaining focus on minimizing use of limited resources. IMPLICATIONS FOR PRACTICE: Patient care plans should be guided by best available evidence to optimize outcomes while maintaining a safe environment in the setting of this pandemic.","Otolaryngol Head Neck Surg","Crosby, Dana L","Sharma, Arun","32340549"],"abstract":["OBJECTIVE: Due to the current coronavirus disease 2019 (COVID-19) pandemic, otolaryngologists face novel challenges when treating patients with head and neck cancer. The purpose of this review is to evaluate the current evidence surrounding the treatment of these patients during this pandemic and to provide evidence-based recommendations with attention to increased risk in this setting. DATA SOURCES: A review of the literature was performed with PubMed. Because recently published articles on this topic may not yet be indexed into PubMed, otolaryngology journals were hand searched for relevant articles. Guidelines from national organizations were reviewed to identify additional relevant sources of information. REVIEW METHODS: Two groups of search terms were created: one with terms related to COVID-19 and another with terms related to head and neck cancer and its management. Searches were performed of all terms in each group as well as combinations of terms between groups. Searches and subsequent exclusion of articles were performed in accordance with the PRISMA guidelines (Preferred Reporting Items for Systematic Reviews and Meta-analyses). Additional articles were identified after relevant journals and guidelines from national organizations were reviewed. CONCLUSIONS: Patients with head and neck mucosal malignancy require continued treatment despite the current pandemic state. Care must be taken at all stages of treatment to minimize the risk to patients and health care workers while maintaining focus on minimizing use of limited resources. IMPLICATIONS FOR PRACTICE: Patient care plans should be guided by best available evidence to optimize outcomes while maintaining a safe environment in the setting of this pandemic."],"journal":"Otolaryngol Head Neck Surg","authors":["Crosby, Dana L","Sharma, Arun"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32340549","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1177/0194599820923623","keywords":["covid-19","sars-cov-2","head and neck cancer","novel coronavirus"],"topics":["Prevention"],"weight":1,"_version_":1666138495129747456,"score":144.19102}]}